SCHEMBL29411475

SCHEMBL29411475

Cc1ncc(C(=O)NCCCc2ccc(-c3ccccc3F)cc2)s1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.48
NPC1 O15118 4/20 0.48
RAB9A P51151 3/20 0.48
USP2 O75604 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
HIF1A Q16665 1/20 0.47
MAPT P10636 5/20 0.46
NAMPT P43490 1/20 0.45
CNR1 P21554 1/20 0.44
ALDH1A1 P00352 2/20 0.43
MEN1 O00255 1/20 0.43
CYP3A4 P08684 1/20 0.43
TSHR P16473 1/20 0.43
MAPKAPK2 P49137 1/20 0.43
KMT2A Q03164 1/20 0.43
ACKR3 P25106 1/20 0.43
HDAC3 O15379 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC7 Q8WUI4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21045185 1.00 SMN1; SMN2 (0.48) SMN1; SMN2NPC1RAB9AUSP2L3MBTL1
SCHEMBL29411613 0.85 NPC1 (0.42) SMN1; SMN2NPC1RAB9AUSP2L3MBTL1
SCHEMBL21045597 0.85 NPC1 (0.42) SMN1; SMN2NPC1RAB9AUSP2L3MBTL1
SCHEMBL21045144 0.84 HDAC3 (0.47) SMN1; SMN2NPC1RAB9AUSP2L3MBTL1
SCHEMBL29411494 0.84 HDAC3 (0.47) SMN1; SMN2NPC1RAB9AUSP2L3MBTL1
SCHEMBL29411370 0.84 HDAC3 (0.50) SMN1; SMN2NPC1RAB9AUSP2L3MBTL1
SCHEMBL21045271 0.84 HDAC3 (0.50) SMN1; SMN2NPC1RAB9AUSP2L3MBTL1
SCHEMBL21045331 0.82 HIF1A (0.49) SMN1; SMN2NPC1RAB9AL3MBTL1HIF1A
SCHEMBL29411657 0.82 HIF1A (0.49) SMN1; SMN2NPC1RAB9AL3MBTL1HIF1A
SCHEMBL21045516 0.81 RAB9A (0.44) SMN1; SMN2NPC1RAB9AUSP2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250188035-A1 TUBULIN INHIBITORS LIN BIOSCIENCE LLC (US) 2025-06-12 US disclosed
US-12247010-B2 Tubulin inhibitors LIN BIOSCIENCE INC. (TW) 2025-03-11 US disclosed
US-20220089539-A1 TUBULIN INHIBITORS LIN BIOSCIENCE INC. (TW) 2022-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220089539-A1 TUBULIN INHIBITORS TUBB3, TUBB1, TUBB SMN1; SMN2 1062/4885NPC1 421/4885RAB9A 959/4885
US-12247010-B2 Tubulin inhibitors TUBB3, TUBB1, TUBB SMN1; SMN2 1062/4885NPC1 421/4885RAB9A 959/4885
US-20250188035-A1 TUBULIN INHIBITORS TUBB3, TUBB1, TUBB SMN1; SMN2 1062/4885NPC1 421/4885RAB9A 959/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.